Paired t test analysis showed that GILZ mRNA levels were significantly lower on PostMPD5 as compared to PostMPD1 values only in RRMS patients, while there was no significant difference in CIS and SPMS patients (p = 0.04) (Fig. 1B). This evidence concerns the gene TSC22D3 and in situ carcinoma.